Benzinga's Top Initiations - CRISPR Therapeutics (NASDAQ:CRSP), Akebia Therapeutics (NASDAQ:AKBA)

Baird initiated coverage on Proofpoint Inc PFPT with an Outperform rating. Proofpoint shares closed at $81.74 on Monday.
Analysts at Evercore ISI Group initiated coverage of Toll Brothers Inc TOL with a Hold rating. Toll Brothers shares closed at $29.22 on Monday.
Analysts at Pacific Crest initiated coverage on Atlassian Corporation PLC TEAM with a Sector Weight rating. Atlassian shares closed at $27.59 on Monday.
Analysts at Citigroup initiated coverage on Oxford Industries Inc OXM with a Buy rating. The price target for Oxford Industries is set to $84. Oxford Industries shares closed at $71.73 on Monday.
Analysts at Evercore ISI Group initiated coverage on D.R. Horton, Inc. DHI with a Buy rating. D.R. Horton shares closed at $27.97 on Monday.
Analysts at Wells Fargo assumed coverage on Newell Brands Inc NWL with an Outperform rating. Newell Brands shares closed at $46.51 on Monday.
Analysts at Aegis Capital initiated coverage on Akebia Therapeutics Inc AKBA with a Buy rating. The price target for Akebia Therapeutics is set to $18. Akebia Therapeutics shares closed at $8.90 on Monday.
Analysts at Citigroup initiated coverage on Crispr Therapeutics AG CRSP with a Neutral rating. The price target for Crispr Therapeutics is set to $19. Crispr Therapeutics shares closed at $17.60 on Monday.
Evercore ISI Group initiated coverage on Lennar Corporation LEN with a Buy rating. Lennar shares closed at $42.33 on Monday.
Wells Fargo assumed coverage on Procter & Gamble Co PG with a Market Perform rating. Procter & Gamble shares closed at $83.00 on Monday.

Market News and Data brought to you by Benzinga APIs